Patents by Inventor Stephane Paul

Stephane Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9560109
    Abstract: A message management facility is described herein that is hosted by a networked node, in a process control network environment, that is separate from a control processor. The message management facility routes a stream of messages received from the control processor to a set of destinations on a supervisory network. By interposing the message management facility on a node that is interposed, in a message steam, between alarm message sources (control processors) and alarm message sinks (workstations, printers, historians), a number of additional functions can be implemented to carry out a number of advanced functions.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: January 31, 2017
    Assignee: Invensys Systems, Inc.
    Inventors: Irvine William Wilson, Markus Stephan Paul, Ewald Gerhard Weiss
  • Patent number: 9123584
    Abstract: A metrology system for gauging and spatially mapping a semiconductor material on a substrate can be used in controlling deposition and thermal activation processes.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: September 1, 2015
    Assignee: FIRST SOLAR, INC
    Inventors: Arnold Allenic, Stephan Paul George, II, Sreenivas Jayaraman, Oleh Petro Karpenko, Chong Lim
  • Publication number: 20140065731
    Abstract: A metrology system for gauging and spatially mapping a semiconductor material on a substrate can be used in controlling deposition and thermal activation processes.
    Type: Application
    Filed: November 5, 2013
    Publication date: March 6, 2014
    Applicant: FIRST SOLAR, INC
    Inventors: Arnold Allenic, Stephan Paul George, II, Sreenivas Jayaraman, Oleh Petro Karpenko, Chong Lim
  • Patent number: 8603839
    Abstract: A metrology system for gauging and spatially mapping a semiconductor material on a substrate can be used in controlling deposition and thermal activation processes.
    Type: Grant
    Filed: July 25, 2011
    Date of Patent: December 10, 2013
    Assignee: First Solar, Inc.
    Inventors: Arnold Allenic, Stephan Paul George, II, Sreenivas Jayaraman, Oleh Karpenko, Chong Lim
  • Publication number: 20130297748
    Abstract: A message management facility is described herein that is hosted by a networked node, in a process control network environment, that is separate from a control processor. The message management facility routes a stream of messages received from the control processor to a set of destinations on a supervisory network. By interposing the message management facility on a node that is interposed, in a message steam, between alarm message sources (control processors) and alarm message sinks (workstations, printers, historians), a number of additional functions can be implemented to carry out a number of advanced functions.
    Type: Application
    Filed: July 1, 2013
    Publication date: November 7, 2013
    Inventors: Irvine William Wilson, Markus Stephan Paul, Ewald Gerhard Weiss
  • Patent number: 8449535
    Abstract: A system and method for assessing a degree of coupling between an electrode and tissue in a body is provided. Values for first and second components of a complex impedance (e.g., resistance and reactance or impedance magnitude and phase angle) between the electrode and the tissue are obtained. From these values, a coupling index is calculated that is indicative of a degree of coupling between the electrode and the tissue. The coupling index may be displayed to a clinician in a variety of ways to indicate the degree of coupling to the clinician. The system and method find particular application in ablation of tissue by permitting a clinician to create lesions in the tissue more effectively and safely.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: May 28, 2013
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Don Curtis Deno, Stephan Paul Miller, Saurav Paul
  • Publication number: 20120021539
    Abstract: A metrology system for gauging and spatially mapping a semiconductor material on a substrate can be used in controlling deposition and thermal activation processes.
    Type: Application
    Filed: July 25, 2011
    Publication date: January 26, 2012
    Inventors: Arnold Allenic, Stephan Paul George, II, Sreenivas Jayaraman, Oleh Karpenko, Chong Lim
  • Patent number: 7947288
    Abstract: The present invention relates to a novel fusion protein with the formula X-Y, or Y-X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: May 24, 2011
    Assignee: Transgene S.A.
    Inventor: Stephane Paul
  • Patent number: 7809523
    Abstract: A method and apparatus for measuring a surface using a surface sensing device mounted on a scanning head on a member of a coordinate positioning apparatus. The coordinate positioning apparatus may be operated to produce relative movement between the scanning head and the surface profile and the scanning head includes a drive for producing rotational movement of the surface sensing probe about one or more axis. A desired measurement profile on the surface which the surface sensing device will track and the desired motion of the orientation of the surface sensing device as the surface' sensing device follows the measurement profile are defined. This data is used to derive the required path of the relative motion between the member of the coordinate positioning apparatus and the surface, such that the surface sensing device prescribes a trajectory along the measurement profile.
    Type: Grant
    Filed: March 23, 2007
    Date of Patent: October 5, 2010
    Assignee: Renishaw PLC
    Inventors: Stephan Paul Hunter, Geoffrey McFarland, Kevyn Barry Jonas, Khaled Mamour
  • Publication number: 20100129403
    Abstract: The present invention concerns new recombinant viral vaccines. In particular the present invention provides combination products that comprise recombinant viral vectors and specific compounds able to improve the immune response raised in vivo by said recombinant viral vectors.
    Type: Application
    Filed: June 15, 2007
    Publication date: May 27, 2010
    Applicant: Transgene S.A.
    Inventors: Jean-Yves Bonnefoy, Stephane Paul
  • Publication number: 20100074869
    Abstract: The present invention relates to a novel fusion protein with the formula X-Y, or Y-X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.
    Type: Application
    Filed: September 15, 2009
    Publication date: March 25, 2010
    Applicant: Transgene, S.A.
    Inventor: Stephane Paul
  • Publication number: 20090223094
    Abstract: The field of the present invention provides for a large automobile that has already been adapted for snow plowing, but having the snow plow removed is then has a folding backhoe apparatus attached to the snow plow attachment points. In a preferred aspect an adapter plate is use and the end of the backhoe can either have a forward or reverse position backhoe shovel (or bucket) attached or have an adapter apparatus that can accept different utility tips such as a post digger drill, a jack hammer or a rake. In a further aspect, snow plow attachment points are attached to an adapter mechanism that can be attached to either a single arm backhoe or a double arm backhoe apparatus.
    Type: Application
    Filed: March 6, 2009
    Publication date: September 10, 2009
    Inventor: Stephan Paul Boyer
  • Patent number: 7534585
    Abstract: The present invention relates to a novel fusion protein with the formula X—Y, or Y—X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.
    Type: Grant
    Filed: July 20, 2004
    Date of Patent: May 19, 2009
    Assignee: Transgene S.A.
    Inventor: Stephane Paul
  • Patent number: 7348014
    Abstract: The present invention concerns a poxviral particle having a targeted infection specificity conferred by an heterologous ligand moiety present at the surface of said poxviral particle and capable of specifically recognizing and binding to an anti-ligand molecule localized at the surface of target cells. The present invention further relates to a vector comprising a nucleotide sequence encoding a chimeric polypeptide including such an heterologous ligand moiety and all or part of a natural poxviral surface polypeptide. The present invention additionally concerns compositions comprising said poxviral particle or said vector as well as their use for therapeutic and prophylactic purposes. The invention is of very special interest in gene therapy applications, in particular in preventing or treating cancer in mammals.
    Type: Grant
    Filed: September 7, 2004
    Date of Patent: March 25, 2008
    Assignee: Transgene, S.A.
    Inventors: Jean Marc Balloul, Stephane Paul, Michel Geist, Nathalle Silvestre, Philippe Erbs
  • Publication number: 20070110713
    Abstract: The present invention relates to a novel fusion protein with the formula X—Y, or Y—X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X. The present invention also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule. The present invention also provides infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles. The present invention also relates to a method for recombinantly producing such a fusion protein. Finally, the present invention also provides a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.
    Type: Application
    Filed: July 20, 2004
    Publication date: May 17, 2007
    Applicant: TRANSGENE S.A.
    Inventor: Stephane Paul
  • Publication number: 20050221435
    Abstract: The invention concerns a biological material for preparing pharmaceutical compositions for treating mammals including either a nucleic acid sequence, containing at least a gene of therapeutic interest and elements expressing the gene in vivo in target cells genetically modified by one such nucleic sequence, or at least a target cell not producing antibodies naturally, genetically modified in vitro by at least one such nucleic acid sequence. The gene of therapeutic interest codes for all or part of an antibody expressed at the surface of the target cell, and such an antibody is capable of fixing itself to a polypeptide present at the surface of a cytotoxic effector cell or a T lymphocyte helper involved in the process activating such a cell.
    Type: Application
    Filed: May 9, 2005
    Publication date: October 6, 2005
    Inventors: Bruce Acres, Stephane Paul
  • Publication number: 20050208074
    Abstract: The present invention concerns a poxviral particle having a targeted infection specificity conferred by an heterologous ligand moiety present at the surface of said poxviral particle and capable of specifically recognizing and binding to an anti-ligand molecule localized at the surface of target cells. The present invention further relates to a vector comprising a nucleotide sequence encoding a chimeric polypeptide including such an heterologous ligand moiety and all or part of a natural poxviral surface polypeptide. The present invention additionally concerns compositions comprising said poxviral particle or said vector as well as their use for therapeutic and prophylactic purposes.
    Type: Application
    Filed: September 7, 2004
    Publication date: September 22, 2005
    Applicant: TRANSGENE S.A.
    Inventors: Jean Balloul, Stephane Paul, Michel Geist, Nathalle Silvestre, Philippe Erbs
  • Publication number: 20050063945
    Abstract: The present invention relates to a novel fusion protein with the formula X—Y, or Y—X, wherein X represents a first immunoregulating polypeptide and Y represents a second immunoregulating polypeptide different from X; it also relates to a nucleic acid molecule encoding such a fusion protein and a vector comprising such a nucleic acid molecule; it also relates to infectious viral particles and host cells comprising such a nucleic acid molecule or such a vector as well as a process for producing such infectious viral particles; is also relates to a method for recombinantly producing such a fusion protein; and, lastly, it also relates to a pharmaceutical composition comprising such a fusion protein, a nucleic acid molecule, a vector, infectious viral particles and a host cell as well as the therapeutic use thereof.
    Type: Application
    Filed: July 21, 2004
    Publication date: March 24, 2005
    Applicant: TRANSGENE S.A.
    Inventor: Stephane Paul
  • Publication number: 20040142885
    Abstract: The invention concerns a biological organism comprising at least: (i) a nucleic acid coding for all or part of an antibody, said antibody being expressed at the surface of a host cell and capable of being fixed to a polypeptide present at the surface of a cytotoxic effector cell or of a T-helper lymphocyte and involved in the process of activating such a cell and (ii) a nucleic acid coding for all or part of a polypeptide involved in the stimulation of an immune response or in attraction to the site of expression and activation of cytotoxic effector cells or of T-helper lymphocytes, said polypeptide being selected among chemokines and co-stimulation molecules. The invention also concerns a host cell and a pharmaceutical composition containing said biological organism and their therapeutic or prophylactic uses.
    Type: Application
    Filed: March 8, 2004
    Publication date: July 22, 2004
    Inventors: Stephane Paul, Etienne Regulier
  • Publication number: 20040135038
    Abstract: A mounting assembly (10) includes an elongate member (12) in the form of a loop to support articles such as pipes. The loop extends around the pipe and into a bracket (24) which forms a tiltable joint through end (16) of the loop (14) held in slots (34) of the bracket (24). The bracket can be secured on a threaded drop rod (44) in order to adjust the position of the elongate member and bracket (26) as required for installation of the pipe.
    Type: Application
    Filed: October 20, 2003
    Publication date: July 15, 2004
    Inventors: Peter Clarence Barton, Stephan Paul Barton
  • Patent number: 5117060
    Abstract: Disclosed is an improved process for the preparation of ketoximes, especially ketoximes derived from branched chain ketones, wherein a ketone is reacted with a hydroxylamine salt in the presence of an alkanol, a heterogeneous base and up to about 5 weight percent, based on the weight of the ketone and alkanol, water.
    Type: Grant
    Filed: June 10, 1991
    Date of Patent: May 26, 1992
    Assignee: Eastman Kodak Company
    Inventor: Jonathan S. Witzeman